News
CR Partner Appointed Co-Chair of Printing-for-Digital Fabrication Conference
Posted on Nov 9, 2017 in News
CR Partner Scott Slomowitz has been appointed publicity co-chair for the Printing-for-Digital Fabrication Conference, sponsored by the Society for Imaging Science and Technology, to be held in Dresden, Germany in September 2018.
Read MoreCR Partner Featured in Academy of Court Appointed Masters Newsletter
Posted on Aug 23, 2017 in News
Caesar Rivise Partner James Kozuch is featured in the August 2017 Academy of Court Appointed Masters (ACAM) Newsletter. The ACAM newsletter spotlights BIEC International, Inc. v. Global Steel Services, Ltd. et al., a complex trade secrets case between two steel-makers in which Mr. Kozuch served as a Special Master.
Read MoreCaesar Rivise Attorneys Named to 2017 Pennsylvania Super Lawyers
Posted on Jun 5, 2017 in News
Eleven Caesar Rivise attorneys have been selected to the 2017 Pennsylvania Super Lawyers list. Each year, no more than five percent of the lawyers in the state are selected through a combination of peer nominations, evaluations, and independent research.
Read More$1.9 Million Awarded to Defendants for Caesar Rivise Attorneys’ Fees in Exceptional Case
Posted on May 22, 2017 in News
In the case of Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc., InvaGen Pharmaceuticals Inc., Civil Action No. 14-4042 (D.N.J.), the Honorable Stanley R. Chesler issued an Order on May 18, 2017 granting defendants’ motion to declare the case exceptional pursuant to 35 U.S.C. § 285, and ordering plaintiff to pay attorneys’ fees in the amount of $1,983,420.60 to defendants.
Read MoreIn Memoriam – Alan H. Bernstein
Posted on Apr 21, 2017 in News
It is with great sadness that the firm announces the passing of retired partner Alan H. Bernstein, who died suddenly on April 15, 2017 at age 84.
Read MoreCaesar Rivise Wins Motion For Attorneys’ Fees In Exceptional Case
Posted on Apr 18, 2017 in News
In the case of Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc., InvaGen Pharmaceuticals Inc., Civil Action No. 14-042 (D.N.J.), the Honorable Stanley R. Chesler on April 12, 2017, granted defendants’ motion to have the case declared “exceptional” pursuant to 35 U.S.C. § 285 and awarded attorneys’ fees in an amount upwards of $2 million.
Read MoreCR Partner Elected Delegate to Pennsylvania Bar Association House of Delegates and Vice President of Bar Association of Lehigh County
Posted on Apr 3, 2017 in News
Caesar Rivise Partner James J. Kozuch was re-elected to serve a three year term as a Delegate to the Pennsylvania Bar Association (“PBA”) House of Delegates representing Zone 2, which comprises Lehigh, Northampton, Berks, Carbon, and Schuylkill Counties. Mr. Kozuch was also elected Vice President of the Bar Association of Lehigh County (“BALC”) in January of this year.
Read MoreRoxane Gets the Red Light from the Federal Circuit
Posted on Nov 17, 2016 in News
On November 17, 2016, in Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc., Invagen Pharmaceuticals Inc., Appeal No. 16-1028, the Court of Appeals for the Federal Circuit sided with Defendants-Appellees Camber and Invagen, for the second time, in holding that the claim term “size 00 or less” meant “precisely size 00 or less” and excluded the elongated version size 00EL which Defendants were using. Robert S. Silver argued the appeal also represented Appellees.
Read MoreManny D. Pokotilow to Receive PNC Achievement Award
Posted on Nov 8, 2016 in News
Manny Pokotilow, senior counsel at Caesar Rivise, PC, will be presented with the PNC Achievement Award at the Philadelphia Bar Association’s Annual Meeting Luncheon on Tuesday, December 7 at the Hyatt at the Bellevue in Philadelphia.
Read MoreCaesar Rivise Attorneys Named to 2017 “Best Lawyers in America”
Posted on Aug 25, 2016 in News
Ten Caesar Rivise attorneys were named to The Best Lawyers in America© 2017 ranking of peer-reviewed professionals. This annual list of carefully vetted attorneys is recognized by Corporate Counsel as “the most respected referral list of attorneys in practice”.
Read More